Get the Stockscreener App
13.52
2.17%
-0.2997
After Hours:
13.52
-0.0039
-0.03%
Homology Medicines Inc Stock (FIXX) Forecast
The Homology Medicines Inc (FIXX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $5.8882, representing a -56.46% decrease from the current price of $13.52. The highest analyst price target is $5.7713, and the lowest is $6.005.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FIXX Price Target
Average 5.4894
(-59.41% Downside)
Is Homology Medicines Inc (FIXX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 0.00 | Neutral |
| STOCH(9,6) | 0.00 | Buy |
| STOCHRSI(14) | 0.00 | Neutral |
| MACD(12,26) | 0.00 | Neutral |
| ADX(14) | 0.00 | Neutral |
| William %R | -100.00 | Buy |
| CCI(14) | 0.00 | Neutral |
Buy: 2
Sell: 0
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
4.1496
Buy
|
0.00
Buy
|
| MA20 |
2.0748
Buy
|
0.00
Buy
|
| MA50 |
0.8299
Buy
|
0.00
Buy
|
| MA100 |
0.415
Buy
|
0.00
Buy
|
| MA200 |
0.2075
Buy
|
0.00
Buy
|
Buy: 10
Sell: 0
Neutral: 0
Summary: Buy
According to our latest analysis, FIXX could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on FIXX, as trading bullish markets is always a lot easier
- RSI (Relative Strength Index): The RSI(14) value of 0 indicates that FIXX is oversold. This indicates that FIXX price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 0 indicates that FIXX is oversold. This indicates that FIXX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 0 indicates that FIXX is oversold. This suggests that FIXX price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 0 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 0 indicates that FIXX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term FIXX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Homology Medicines Inc financial reports and earnings history, Homology Medicines Inc (FIXX) stock could reach $24.50 by 2030, $10.68 by 2040 and $39.69 by 2050. See the projected annual prices until 2050 of the Homology Medicines Inc stock below:
- Homology Medicines Inc (FIXX) is expected to reach an average price of $2.4448 in 2035, with a high prediction of $2.897 and a low estimate of $2.4628. This indicates an $-81.92% rise from the last recorded price of $13.52.
- Homology Medicines Inc (FIXX) stock is projected to chart a bullish course in 2040, with an average price target of $10.22, representing an $-24.43% surge from its current level. The forecast ranges from a conservative $10.30 to a sky-high $10.68.
- Our analysts predict Homology Medicines Inc (FIXX) to jump 63.02% by 2045, soaring from $22.43 to an average price of $22.05, potentially reaching $22.93. While $22.43 is the low estimate, the potential upside is significant.
- Homology Medicines Inc (FIXX) stock is expected to climb by 2050, reaching an average of $38.26, a $182.91% jump from its current level. However, a wide range of estimates exists, with high and low targets of $39.69 and $38.57, respectively, highlighting the market's uncertainty.
Homology Medicines Inc Stock (FIXX) Year by Year Forecast
Homology Medicines Inc Stock (FIXX) Price Forecast for 2026
The predicted value for Homology Medicines Inc (FIXX) in 2026 is set at an average of $4.1745. Estimates vary from a peak of $7.0214 to a trough of $1.3277, indicating an -69.13% surge from the present price of $13.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| September, 2026 | $6.005 | $6.005 | $5.7713 | -55.60% |
| October, 2026 | $5.7612 | $6.3212 | $6.01 | -57.40% |
| November, 2026 | $5.0962 | $5.2762 | $5.4669 | -62.32% |
| December, 2026 | $4.0224 | $3.9212 | $4.4409 | -70.26% |
Homology Medicines Inc Stock (FIXX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Homology Medicines Inc (FIXX) is $5.7098, with a high forecast of $7.286 and a low forecast of $4.1337. This indicates an -57.78% decrease from the last price of $13.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.5774 | $4.1337 | $5.2974 | -58.76% |
| February, 2027 | $6.0924 | $5.6711 | $5.5086 | -54.95% |
| March, 2027 | $6.5173 | $6.0948 | $5.8761 | -51.81% |
| April, 2027 | $6.8635 | $6.8398 | $6.6485 | -49.25% |
| May, 2027 | $6.2885 | $6.6285 | $6.7548 | -53.50% |
| June, 2027 | $6.4335 | $6.436 | $7.0222 | -52.43% |
| July, 2027 | $6.4897 | $6.5984 | $6.326 | -52.01% |
| August, 2027 | $7.4347 | $6.4909 | $7.0576 | -45.03% |
| September, 2027 | $7.3109 | $7.4271 | $7.286 | -45.94% |
| October, 2027 | $6.7158 | $6.8058 | $7.0221 | -50.34% |
| November, 2027 | $5.9208 | $6.3808 | $6.2983 | -56.22% |
| December, 2027 | $5.037 | $5.447 | $5.6873 | -62.75% |
Homology Medicines Inc Stock (FIXX) Price Forecast for 2028
In 2028, Homology Medicines Inc (FIXX) is projected to reach an average price of $4.1955, with a high projection of $5.517 and a low estimate of $2.8741. This indicates an -68.98% fall from the last price of $13.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $5.302 | $5.2395 | $5.132 | -60.80% |
| February, 2028 | $5.557 | $5.3406 | $5.517 | -58.91% |
| March, 2028 | $5.2832 | $5.3132 | $5.4894 | -60.93% |
| April, 2028 | $4.9081 | $4.9381 | $5.0657 | -63.71% |
| May, 2028 | $4.7731 | $4.7931 | $4.8094 | -64.71% |
| June, 2028 | $4.1093 | $4.2493 | $4.7256 | -69.61% |
| July, 2028 | $4.0293 | $4.013 | $3.9156 | -70.21% |
| August, 2028 | $3.8105 | $3.7293 | $3.8055 | -71.82% |
| September, 2028 | $3.7155 | $3.7475 | $3.7442 | -72.53% |
| October, 2028 | $3.4104 | $3.5104 | $3.5967 | -74.78% |
| November, 2028 | $3.0316 | $3.0666 | $3.3017 | -77.58% |
| December, 2028 | $2.8166 | $2.8741 | $2.8006 | -79.17% |
Homology Medicines Inc Stock (FIXX) Price Forecast for 2029
The 2029 price forecast for Homology Medicines Inc Stock (FIXX) is $12.38 on average, with a high prediction of $24.73 and a low estimate of $0.0255. This represents an -8.46% decrease from the previous price of $13.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $2.0566 | $2.4566 | $2.7429 | -84.79% |
| February, 2029 | $1.9916 | $1.9474 | $1.8578 | -85.27% |
| March, 2029 | $1.5078 | $1.5228 | $1.7818 | -88.85% |
| April, 2029 | $1.2627 | $1.3627 | $1.359 | -90.66% |
| May, 2029 | $0.9589 | $0.9986 | $1.1552 | -92.91% |
| June, 2029 | $1.1129 | $1.1289 | $1.2314 | -91.77% |
| July, 2029 | $0.7309 | $0.7778 | $0.9852 | -94.60% |
| August, 2029 | $0.2751 | $0.306 | $0.6201 | -97.97% |
| September, 2029 | $0.232 | $0.0255 | $0.2499 | -98.28% |
| October, 2029 | $0.6007 | $0.2827 | $0.6406 | -95.56% |
| November, 2029 | $22.93 | $0.6187 | $22.43 | +69.58% |
| December, 2029 | $26.26 | $25.05 | $24.73 | +94.21% |
Homology Medicines Inc Stock (FIXX) Price Forecast for 2030
Homology Medicines Inc Stock (FIXX) is expected to reach an average price of $23.34 in 2030, with a high forecast of $28.00 and a low forecast of $18.67. This signifies an +72.57% surge from the last price of $13.52.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $23.27 | $24.95 | $24.50 | +72.04% |
| February, 2030 | $27.32 | $25.97 | $26.07 | +101.99% |
| March, 2030 | $22.49 | $24.33 | $26.21 | +66.27% |
| April, 2030 | $23.94 | $22.86 | $23.71 | +77.00% |
| May, 2030 | $28.15 | $25.81 | $27.82 | +108.14% |
| June, 2030 | $25.87 | $27.33 | $28.00 | +91.28% |
| July, 2030 | $18.90 | $20.51 | $24.11 | +39.77% |
| August, 2030 | $21.90 | $18.67 | $21.00 | +61.95% |
| September, 2030 | $19.84 | $20.34 | $21.99 | +46.68% |
| October, 2030 | $24.18 | $21.14 | $22.25 | +78.82% |
| November, 2030 | $18.49 | $21.15 | $21.06 | +36.75% |
| December, 2030 | $23.68 | $23.65 | $23.63 | +75.12% |
1.21%
1.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):